drug

nicotine

Nicotine
MeSH D009538
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by US Department of Veterans Affairs
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects
NCT00690170Phase 1Completed
5HT3 Antagonism and Auditory Gating in Schizophrenia
NCT00018850—Completed

KOLs & investigators

1
Deepak C D'Souza, M.D.KOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
US Department of Veterans Affairs
company
trial
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects
PHASE1
trial
5HT3 Antagonism and Auditory Gating in Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Cognition Disorders
indication
Healthy Subjects
indication
KOL
Deepak C D'Souza, M.D.
KOL score 5
person